| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +100.00% | -7.44% | -0.40% | -7.04% | -5.46% | — |
| 14d | 4 | +75.00% | -4.67% | -0.54% | -4.13% | -2.96% | — |
| 30d | 4 | +75.00% | +4.61% | +0.98% | +3.63% | -5.07% | — |
| 60d | 4 | +50.00% | +5.02% | +3.77% | +1.25% | -0.64% | — |
| 90d | 4 | +75.00% | -7.74% | +4.48% | -8.79% | -8.91% | — |
| 180d | 4(1 pending) | +66.67% | -13.25% | +10.00% | -16.96% | -16.96% | — |
| 1y | 4(3 pending) | +100.00% | -26.01% | +23.08% | -49.09% | -49.09% | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| MGX METAGENOMI THERAPEUTICS, INC. | SALE See Remarks | 3,737 | $1.30 | $4.9K | 377,533 | Jun 5, 2026 | Jun 10, 2026 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 276,000 | — | — | 276,000 | Apr 1, 2026 | Apr 3, 2026 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 46,000 | — | — | 379,770 | Apr 1, 2026 | Apr 3, 2026 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,607 | $1.60 | $2.6K | 333,770 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | SALEGRANT Gift | 228,462 | — | — | 335,377 | Dec 5, 2025 | Mar 9, 2026 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,602 | $1.77 | $2.8K | 563,839 | Dec 5, 2025 | Dec 8, 2025 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 37,500 | $1.60 | $60.0K | 354,441 | Dec 1, 2025 | Dec 1, 2025 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 211,000 | $1.60 | $337.6K | 565,441 | Dec 1, 2025 | Dec 1, 2025 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 225,000 | — | — | 225,000 | Dec 1, 2025 | Dec 1, 2025 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | SALE Chief Executive Officer | 1,602 | $1.81 | $2.9K | 316,941 | Sep 5, 2025 | Dec 1, 2025 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | SALE See Remarks | 6,390 | $1.75 | $11.2K | 315,543 | Jun 6, 2025 | Jun 9, 2025 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 140,000 | — | — | 140,000 | Apr 1, 2025 | Apr 3, 2025 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 23,000 | — | — | 321,933 | Apr 1, 2025 | Apr 3, 2025 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 296,308 | — | — | 296,308 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |
| MGX METAGENOMI THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,471 | — | — | 298,933 | Apr 1, 2024 | Apr 3, 2024 ↗ | View → |